RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Effect of Rosiglitazone on Myocardial Ischemia-Reperfusion Injury in Rat Heart

      한글로보기

      https://www.riss.kr/link?id=A104667459

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      This study was undertaken to evaluate whether peroxisome proliferator-activated-receptor-gamma (PPAR-γ) agonist-rosiglitazone (ROSI) induces postischemic functional recovery in Langendorf heart model. Hearts isolated from normal rats were subjected t...

      This study was undertaken to evaluate whether peroxisome proliferator-activated-receptor-gamma (PPAR-γ) agonist-rosiglitazone (ROSI) induces postischemic functional recovery in Langendorf heart model. Hearts isolated from normal rats were subjected to 20 min of normoxia or 25 min zero-flow ischemia followed by 50 min reperfusion. In this acute protocol, ROSI (20μg/ml) administered 10 min before ischemia had no effect on hemodynamic cardiac function, but had protective effect on lipid peroxidation in in vitro experiments. In chronic protocol in which ROSI was given by daily gavage (4 mg/kg) for three consecutive days, ROSI could not prevent the hemodynamic alteration on cardiac performance, but has protective effect on the activity of superoxide dismutase (SOD). There was no significant difference in the contents of reduced glutathione (GSH) and catalase activity between ischemia-reperfusion (IR) and ROSI treated IR hearts. Although ROSI had no effect on hemodynamic factor, it had effect on antioxidant activity. Our results indicate that ROSI provides partial beneficial effects by inhibiting lipid peroxidation and/or recovering normal level of SOD activity in the ischemic reperfused heart.

      더보기

      참고문헌 (Reference)

      1 "Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart" 51 : 1110-1117, 2002

      2 "The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart" 77 : 465-485, 1982

      3 "The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins" 27 : 681-687, 1993

      4 "Rosiglitazone, a peroxisome proliferator- activated receptor-gamma, inhibits the Jun NH2-terminal kinase/ activating protein 1 pathway and protects the heart from ischemia/reperfusion injury" 51 : 1507-1514, 2002

      5 "Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion Correlation with the progression of cell injury" 1770-1780, 1985

      6 "Peroxisome proliferator-activated receptors in the cardiovascular system" 129 : 823-834, 2000

      7 "Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes" 87 : 596-602, 2000

      8 "Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts" 87 : 2056-2066, 1991

      9 "Myocardial adaptation to ischemia by oxidative stress induced by endotoxin" 269 : 907-916, 1995

      10 "Mechanisms of autoprotection and the role of stress-proteins in natural defenses, autoprotection, and salutogenesis" 51 : 153-163, 1998

      1 "Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart" 51 : 1110-1117, 2002

      2 "The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart" 77 : 465-485, 1982

      3 "The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins" 27 : 681-687, 1993

      4 "Rosiglitazone, a peroxisome proliferator- activated receptor-gamma, inhibits the Jun NH2-terminal kinase/ activating protein 1 pathway and protects the heart from ischemia/reperfusion injury" 51 : 1507-1514, 2002

      5 "Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion Correlation with the progression of cell injury" 1770-1780, 1985

      6 "Peroxisome proliferator-activated receptors in the cardiovascular system" 129 : 823-834, 2000

      7 "Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes" 87 : 596-602, 2000

      8 "Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts" 87 : 2056-2066, 1991

      9 "Myocardial adaptation to ischemia by oxidative stress induced by endotoxin" 269 : 907-916, 1995

      10 "Mechanisms of autoprotection and the role of stress-proteins in natural defenses, autoprotection, and salutogenesis" 51 : 153-163, 1998

      11 "Mechanisms and consequences of lipid peroxidation in biological systems" 5 : 365-390, 1985

      12 "Magnesium and reperfusion of ischemic rat heart as assessed by 31P-NMR" 256 : 1989

      13 "Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart" 263 : 1992

      14 "In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone" 104 : 2588-2594, 2001

      15 "In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone" 104 : 2588-2594, 2001

      16 "Importance of timing of magnesium administration:a study on the isolated ischemic-reperfused rat heart" 12 : 37-42, 1999

      17 "Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists" 272 : 8071-8076, 1997

      18 "Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest" 59 : 428-432, 1995

      19 "Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress" 27 : 181-193, 1995

      20 "Free-radical oxidation and antioxidants" 1 : 647-650, 1978

      21 "Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs" 97 : 562-576, 1996

      22 "Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions" 129 : 179-186, 1993

      23 "Differential expression of peroxisome proliferator-activated receptors (PPARs) tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat" 137 : 354-366, 1996

      24 "Deleterious effects of oxygen radicals in ischemia/reperfusion" 1115-80 1127, 1989

      25 "Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats" 45 : 1168-1173, 1996

      26 "Basic and clinical aspects of myocardial stunning" 40 : 477-516, 1998

      27 "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction" 95 : 351-358, 1979

      28 "Acute hemodynamic effects of insulin-sensitizing agents in isolated perfused rat hearts" 400 : 113-119, 2000

      29 "Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart Correlation with the loss of contractile function and the development of calcium overload" 238-245, 1986

      30 "A spectrophotometric method for measuring the breakdown of hydrogen peroxide be catalase" 195 : 133-140, 1952

      31 "A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding" 72 : 248-254, 1976

      32 "A new colorimetric method for the determination of glutathione in erythrocytes" 53 : 153-161, 1974

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-04-29 학술지명변경 외국어명 : THE KOREAN JOURNAL OF Physiology & Pharmacology -> The Korean Journal of Physiology & Pharmacology KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-10-12 학술지명변경 한글명 : 대한 생리.약리학회지 -> The Korean Journal of Physiology & Pharmacology
      외국어명 : THE KOREAN JOURNAL OF Physilogy & Pharmacology -> THE KOREAN JOURNAL OF Physiology & Pharmacology
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.85 0.36 1.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.05 0.9 0.575 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼